ORYZON Publishes Paper in Journal of Clinical Oncology Demonstrating Relevance of Iadademstat in Leukemia

NEXT STORY
Genmab to Host Capital Markets Day
PREV STORY
OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Health Receives ISO 13485 Certification

SAN DIEGO, July 03, 2018 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare ...

author_avatar
NASDAQ Market News

Aceragen’s wholly-owned subsidiary, Arrevus, awarded $45 million funding agreement from the Department of Defense’s Defense Threat Reduction Agency for Development of ACG-701 as Medical Countermeasure Against Melioidosis

author_avatar
NASDAQ Market News

Worldwide Diabetes Management: Insulin Pumps Market Outlook to 2022 – Medtronic’s Dominant Market Share May be Threatened in the Coming Years

author_avatar
NASDAQ Market News